Diagnostics

Hyland Showcases Enterprise Imaging Innovation at RSNA 2025: Empowering Personalized, Connected Care

From radiology and cardiology to digital pathology and multi-specialty imaging, Hyland enables a single, secure, and interoperable imaging record that…

3 weeks ago

Bracco Imaging Achieves New Global Milestone with ANVISA Clearance of AiMIFY™ in Brazil

Regulatory Approval Expands Access to AI-Powered Diagnostics Across Latin America, Following FDA and CE Mark Clearances MILAN, Nov. 20, 2025 /PRNewswire/…

3 weeks ago

Plus Therapeutics Secures National Coverage Agreement with Humana for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

HOUSTON, Nov. 20, 2025 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”),…

3 weeks ago

Vascular Imaging Market worth US$4.54 billion by 2030 with 7.3% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Nov. 19, 2025 /PRNewswire/ -- The global Vascular Imaging Market, valued at US$3.03 billion in 2024, stood…

4 weeks ago

DELIVERING SIGNIFICANT COST REDUCTIONS AND FASTER ACCESS TO CARE, BIOLABS INTERNATIONAL LLC LAUNCHES AFFORDABLE “TEST-TO-TREAT” SOLUTION WITH SPEEDYSWAB®

SAN DIEGO, Nov. 19, 2025 /PRNewswire/ -- As potential changes to the Affordable Care Act (ACA) place millions of Americans…

4 weeks ago

Philips and Cortechs.ai extend partnership to advance quantitative neuroimaging and strengthen Philips’ leadership in precision diagnostics in neurology

Clinician views Cortechs.ai neuroimaging analytics Clinician views Cortechs.ai neuroimaging analytics November 19, 2025Amsterdam, the Netherlands – Royal Philips (NYSE: PHG,…

4 weeks ago

DeepView™ System Featured at 2025 US Burn Conferences

DALLAS, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence…

4 weeks ago

Beacon Biosignals Announces Multi-Year Expansion of Strategic Collaboration with Takeda to Advance Narcolepsy Diagnosis and Neurobiomarker Discovery

BOSTON, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Beacon Biosignals, a leading neurotechnology company powering AI-driven neurodiagnostics and precision medicines for…

4 weeks ago

BioPorto Interim Result for the Third Quarter of 2025 – Continued progress and continued NGAL sales growth

November 19, 2025 Announcement no. 26 BioPorto Interim Result for the Third Quarter of 2025 – Continued progress and continued…

4 weeks ago

European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lymphoma

Lunsumio provides high rates of deep and long-lasting responses in third-line and later follicular lymphoma, a disease that typically becomes…

4 weeks ago